New Jersey Tasigna Multi-county Litigation (MCL), Federal Court Tasigna Multidistrict Litigation (MDL) (Posted by Tom Lamb at Drug Injury Watch) In early June 2021, the New Jersey Supreme Court consolidated Tasigna drug injury lawsuits filed against Novartis Pharmaceuticals Corp. before one judge for pretrial proceedings as part of a New Jersey state court multi-county litigation (MCL). And in Jul

And Novartis "has yet to identify the root cause behind Beovu’s safety problem", According to a News Report (Posted by Tom Lamb at Drug Injury Watch) Starting back in February 2020, when the American Society of Retinal Specialists (ASRS) issued a note to members about 14 cases of retinal vasculitis, Beovu vision loss side effects have handed Novartis setbacks in its efforts to capture market share

May 2021 FDA Drug Safety Communication: Ocaliva Label Change: Prescribing Information Will be Adding and Updating Warnings (Posted by Tom Lamb at Drug Injury Watch) Ocaliva (obeticholic acid) was listed on the "April - June 2020 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)" report for "Liver disorder", and the status as of